Interface Biologics Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Interface Biologics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6468
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Interface Biologics Inc (IBI) is a medical device company that develops transformative biomedical polymer technologies. The company offers anti-thrombogenic and combination drug delivery devices. Its anti-thrombogenic additives reduce thrombosis in blood contacting medical devices and polymer enabled drug delivery platforms. IBI’s technologies include endexo, kinesyx and epidel. The company provides combination drug delivery devices which include Epidel and Kinesyx. Its products improve the safety and effectiveness of implantable medical devices. The company serves dialysis patients in Canada and abroad. IBI is headquartered in Toronto, Ontario, Canada.

Interface Biologics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Interface Biologics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Interface Biologics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Interface Biologics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Interface Biologics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Interface Biologics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Interface Biologics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Interface Biologics Raises Funds Through Extended Series B Venture Financing 10
Partnerships 11
AngioDynamics Extends Licensing Agreement With Interface Biologics To Include Central Venous Catheters 11
Interface Biologics To Enter Into Co-Development Agreement With Qualimed Innovative Medizinprodukte 12
Interface Biologics Inc – Key Competitors 13
Interface Biologics Inc – Key Employees 14
Interface Biologics Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Interface Biologics Inc, Medical Equipment, Key Facts 2
Interface Biologics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Interface Biologics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Interface Biologics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Interface Biologics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Interface Biologics Inc, Deals By Market, 2012 to YTD 2018 8
Interface Biologics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Interface Biologics Raises Funds Through Extended Series B Venture Financing 10
AngioDynamics Extends Licensing Agreement With Interface Biologics To Include Central Venous Catheters 11
Interface Biologics To Enter Into Co-Development Agreement With Qualimed Innovative Medizinprodukte 12
Interface Biologics Inc, Key Competitors 13
Interface Biologics Inc, Key Employees 14

List of Figures
Interface Biologics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Interface Biologics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Interface Biologics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Interface Biologics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Interface Biologics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Interface Biologics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Interface Biologics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Interface Biologics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Interface Biologics Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223):医療機器:M&Aディール及び事業提携情報
    Summary Jiangsu Yuyue Medical Equipment & Supply Co Ltd (Jiangsu Yuyue) is a medical device company that manufactures and distributes various medical equipments. The company’s products include electronic blood pressure monitor, air sterilization purifier, X-ray machine, blood glucose meter, temperat …
  • IPCA Laboratories Ltd (IPCALAB):企業の財務・戦略的SWOT分析
    Summary IPCA Laboratories Ltd (IPCA) is a manufacturer and supplier of active pharmaceutical ingredients (API’s), generics and branded formulations. It is one of India's largest formulation exporters and is specialized in anti-malarial and anti-bacterials therapeutic segments. The company offers API …
  • Young & Co.’s Brewery plc (YNGA):企業の財務・戦略的SWOT分析
    Young & Co.'s Brewery plc (YNGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Varex Imaging Corp (VREX):企業の財務・戦略的SWOT分析
    Varex Imaging Corp (VREX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Territorial Generation Company No. 11:企業の戦略的SWOT分析
    Territorial Generation Company No. 11 - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Lantronix, Inc. (LTRX):企業の財務・戦略的SWOT分析
    Lantronix, Inc. (LTRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • MITIE Group plc (MTO):企業の財務・戦略的SWOT分析
    MITIE Group plc (MTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Skanska AB (SKA B):企業の財務・戦略的SWOT分析
    Skanska AB (SKA B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Black Knight Financial Services, Inc. (BKFS):企業の財務・戦略的SWOT分析
    Black Knight Financial Services, Inc. (BKFS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • IRWIN Industrial Tool Co:企業の戦略的SWOT分析
    IRWIN Industrial Tool Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Regeneron Pharmaceuticals Inc (REGN):企業の財務・戦略的SWOT分析
    Regeneron Pharmaceuticals Inc (REGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • EWE AG:電力:M&Aディール及び事業提携情報
    Summary EWE AG (EWE) operates in energy, telecommunication and information technology businesses. The company is involved in generation and transmission of energy, gas storage and waste water treatment. EWE plans, builds and operates renewable power generation plants globally. The company operates c …
  • Siemens Healthcare GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Siemens Healthcare GmbH d/b/a Siemens Healthineers, a subsidiary of Siemens AG, is a global medical device company that designs, develops, manufactures and distributes medical devices and technologies for diagnostic markets. Its major products include healthcare IT and medical infrastructure …
  • ONCOVEDA Cancer Research Center:企業の製品パイプライン分析
    Summary ONCOVEDA Cancer Research Center (Oncoveda), a part of Medical Diagnostic Laboratories LLC, is a cancer research center. The center provides research and development programs for cancer, early detection, monitoring, and treatment of bladder and endometrial cancers, and tumor progression and r …
  • SFL Corp Ltd (SFL):企業の財務・戦略的SWOT分析
    Summary SFL Corp Ltd (SFL) is engaged in providing bulker, tanker, container, and offshore solutions. The company offers fleet of vessels such as crude oil tankers for ultra-deep water semi-submersible, dry bulk carriers and drilling rigs, among others. In addition, it also operates car carriers, of …
  • TopiVert Ltd-製薬・医療分野:企業M&A・提携分析
    Summary TopiVert Ltd (TopiVert) is a drug development company that offers disease control solutions in inflammatory diseases of the gastrointestinal tract and the eye. The company develops and offers narrow spectrum kinase inhibitors (NSKI) for the treatment of chronic inflammatory diseases of gastr …
  • Pegasystems Inc (PEGA):企業の財務・戦略的SWOT分析
    Pegasystems Inc (PEGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • AveXis Inc (AVXS):製薬・医療:M&Aディール及び事業提携情報
    Summary AveXis Inc (AveXis), formerly BioLife Cell Bank Inc, is a biotechnology company that develops innovative treatments for rare and potentially fatal neurological genetic diseases. The company offers AVXS-101, a proprietary gene therapy candidate in phase 1 targeted at the treatment of spinal m …
  • Genting Berhad:企業の戦略・SWOT・財務分析
    Genting Berhad - Strategy, SWOT and Corporate Finance Report Summary Genting Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Alps Industries Ltd.:企業の戦略・SWOT・財務情報
    Alps Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Alps Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆